File photo: REUTERS/Athit Perawongmetha
Thailand on Wednesday (September 1) reported 14,802 new COVID-19 cases, 18,996 recoveries and 252 additional deaths over the past 24 hours.
● 18,996 recoveries
● 14,585 new infections
● 217 prison / prison infections
Wednesday’s cases bring the total number of COVID-19 infections in Thailand to 1,219,531 with 11,841 deaths.
(Total infections since April 1: 1,190,668)
The news comes as Chulalongkorn University researchers have launched the second phase of human trials of the Chula-Cov19 mRNA vaccine, after the Phase 1 trial greatly boosted volunteers’ antibodies against the COVID-19 virus.
Chula-Cov19 mRNA development program Director Dr. Kiat Ruxrungtham said the vaccine proved effective against all four variants of the virus in Phase 1 and is expected to be registered by the Thai Food and Drug Administration (TFDA) in April next year. The vaccine can induce a very strong antibody response.
He said, after being injected with the mRNA vaccine, Phase 1 volunteers developed 94% protection against COVID-19 symptoms, with high antibody activation.
(Source: – Asean Now)